Results 41 to 50 of about 1,287,062 (370)
Acute parkinsonism secondary to SARS Cov 2 infection. [PDF]
Batna Journal of Medical Sciences, 2023 SARS Cov 2 or Corona virus is a respiratory virus, responsible for a new pandemic since 2019. Main symptoms revolve around respiratory manifestations. Nevertheless, many extra-respiratory attacks are attributed to it.
Mohamed Islam Kediha +3 more
doaj +1 more source
Mechanisms of SARS-CoV-2 entry into cells
Nature reviews. Molecular cell biology, 2021 The unprecedented public health and economic impact of the COVID-19 pandemic caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been met with an equally unprecedented scientific response.
C. B. Jackson +3 more
semanticscholar +1 more source
Cardiovascular disease in SARS‐CoV‐2 infection
Clinical & Translational Immunology, 2021 Pre‐existing cardiovascular disease (CVD) increases the morbidity and mortality of COVID‐19 and is strongly associated with poor disease outcomes. However, SARS‐CoV‐2 infection can also trigger de novo acute and chronic cardiovascular disease.
Kei Sato +5 more
doaj +1 more source
Nature Reviews Microbiology, 2023 Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused millions of deaths and substantial morbidity worldwide. Intense scientific effort to understand the biology of SARS-CoV-2 has resulted in daunting numbers of genomic sequences. We witnessed evolutionary events that could mostly be inferred indirectly before, such as the emergence ...
Peter V. Markov +6 more
openaire +2 more sources
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity [PDF]
, 2020 On 7 January 2020, researchers isolated and sequenced in China from patients with severe pneumonitis a novel coronavirus, then called SARS-CoV-2, which rapidly spread worldwide, becoming a global health emergency.
Diamanti, A. P. +4 more
core +2 more sources
Coronavirus in Continuous Flux: From SARS‐CoV to SARS‐CoV‐2
Advanced Science, 2020 The world is currently experiencing a global pandemic caused by a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), which causes severe respiratory disease similar to SARS.
Yetian Dong +4 more
doaj +1 more source
Racing for a SARS‐CoV‐2 vaccine
EMBO Molecular Medicine, 2021 Graphical Abstract Interview with EMBO Members Özlem Türeci and Uğur Şahin, BioNTech, conducted by science journalist Kai Kupferschmidt.
Özlem Türeci, Uğur Şahin
doaj +1 more source
Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China
Allergy. European Journal of Allergy and Clinical Immunology, 2020 Coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection has been widely spread. We aim to investigate the clinical characteristic and allergy status of patients infected with SARS‐CoV‐2.
Jin-Jin Zhang +7 more
semanticscholar +1 more source
Prevention of infection and disruption of the pathogen transfer chain in elective surgery [PDF]
, 2020 The COVID-19 pandemic has caused us all to stop our normal activities and consider how we can safely return to caring for our patients. There are many common practices (such as an increased use of personal protective equipment) which we are all familiar ...
Chisari, Emanuele +5 more
core +2 more sources
The Infectious Disease Ontology in the Age of COVID-19 [PDF]
, 2021 The Infectious Disease Ontology (IDO) is a suite of interoperable ontology modules that aims to provide coverage of all aspects of the infectious disease domain, including biomedical research, clinical care, and public health.
Babcock, Shane +3 more
core +1 more source